fails

Semaglutide Fails to Slow Alzheimer’s Progression in Pivotal Phase 3 Trials, Halting Further Development for the Condition.

Semaglutide, an anti-diabetic medication widely known under brand names like Ozempic, Rybelsus, and Wegovy, did not demonstrate a statistically significant…